Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.

Reunion Neuroscience Inc.

Field Trip Health provides psychedelic therapies aimed at treating emotional trauma and mental health challenges, utilizing medical treatments combined with virtual integration therapy.

REUN

COM:FIELDTRIPHEALTH

Field Trip Health

Last Close

1.46

02/08 18:41

Market Cap

16.64M

Beta: -

Volume Today

339

Avg: -

Financials Not Available